Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Watanabe

Showing results (231-240 of 238) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 238 results.
Journal of Virology|April 21, 2017
Simian Immunodeficiency Virus Targeting of CXCR3<sup>+</sup> CD4<sup>+</sup> T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage SubsetsMasayuki Fujino, Hirotaka Sato, Tomotaka Okamura, et al.
Elife|May 24, 2024
Secreted dengue virus NS1 from infection is predominantly dimeric and in complex with high-density lipoproteinBing Liang Alvin Chew, A N Qi Ngoh, Wint Wint Phoo, et al.
Annals of the American Thoracic Society|March 28, 2025
Intermittent versus Daily Therapy for Noncavitary <i>Mycobacterium avium</i> Complex Pulmonary Disease: An Open-label Randomized TrialTaku Nakagawa, Kohei Fujita, Mari Miki, et al.
Nature Communications|March 14, 2018
A systematic approach to the development of a safe live attenuated Zika vaccineSwee Sen Kwek, Satoru Watanabe, Kuan Rong Chan, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
The Lancet. Infectious Diseases|June 1, 2014
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trialJenny G Low, Cynthia Sung, Limin Wijaya, et al.
Journal of Medicinal Chemistry|March 10, 2026
Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5'-Terminal Oligopyrimidine Motif-Containing mRNAChin Piaw Gwee, Tommaso Felicetti, Kitti Wing Ki Chan, et al.
Science Translational Medicine|April 7, 2010
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese populationHirotaka Matsuo, Tappei Takada, Kimiyoshi Ichida, et al.
Pageof 24

Showing results (231-240 of 238) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 238 results.
Journal of Virology|April 21, 2017
Simian Immunodeficiency Virus Targeting of CXCR3<sup>+</sup> CD4<sup>+</sup> T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage SubsetsMasayuki Fujino, Hirotaka Sato, Tomotaka Okamura, et al.
Elife|May 24, 2024
Secreted dengue virus NS1 from infection is predominantly dimeric and in complex with high-density lipoproteinBing Liang Alvin Chew, A N Qi Ngoh, Wint Wint Phoo, et al.
Annals of the American Thoracic Society|March 28, 2025
Intermittent versus Daily Therapy for Noncavitary <i>Mycobacterium avium</i> Complex Pulmonary Disease: An Open-label Randomized TrialTaku Nakagawa, Kohei Fujita, Mari Miki, et al.
Nature Communications|March 14, 2018
A systematic approach to the development of a safe live attenuated Zika vaccineSwee Sen Kwek, Satoru Watanabe, Kuan Rong Chan, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
The Lancet. Infectious Diseases|June 1, 2014
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trialJenny G Low, Cynthia Sung, Limin Wijaya, et al.
Journal of Medicinal Chemistry|March 10, 2026
Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5'-Terminal Oligopyrimidine Motif-Containing mRNAChin Piaw Gwee, Tommaso Felicetti, Kitti Wing Ki Chan, et al.
Science Translational Medicine|April 7, 2010
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese populationHirotaka Matsuo, Tappei Takada, Kimiyoshi Ichida, et al.
Pageof 24